ExxonMobil's Nigerian asset sale nears approval    Argentina's GDP to contract by 3.3% in '24, grow 2.7% in '25: OECD    Chubb prepares $350M payout for state of Maryland over bridge collapse    Turkey's GDP growth to decelerate in next 2 years – OECD    EU pledges €7.4bn to back Egypt's green economy initiatives    Yen surges against dollar on intervention rumours    $17.7bn drop in banking sector's net foreign assets deficit during March 2024: CBE    Norway's Scatec explores 5 new renewable energy projects in Egypt    Egypt, France emphasize ceasefire in Gaza, two-state solution    Microsoft plans to build data centre in Thailand    Japanese Ambassador presents Certificate of Appreciation to renowned Opera singer Reda El-Wakil    WFP, EU collaborate to empower refugees, host communities in Egypt    Health Minister, Johnson & Johnson explore collaborative opportunities at Qatar Goals 2024    Egypt facilitates ceasefire talks between Hamas, Israel    Al-Sisi, Emir of Kuwait discuss bilateral ties, Gaza takes centre stage    AstraZeneca, Ministry of Health launch early detection and treatment campaign against liver cancer    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    AstraZeneca injects $50m in Egypt over four years    Egypt, AstraZeneca sign liver cancer MoU    Swiss freeze on Russian assets dwindles to $6.36b in '23    Amir Karara reflects on 'Beit Al-Rifai' success, aspires for future collaborations    Climate change risks 70% of global workforce – ILO    Prime Minister Madbouly reviews cooperation with South Sudan    Ramses II statue head returns to Egypt after repatriation from Switzerland    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Debt swaps could unlock $100b for climate action    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Rameda private placement oversubscribed 1.17 fold
Egypt's second private-sector initial public offering (IPO) of the year, revitalising the country's lacklustre IPO market, is the largest Egyptian IPO and has been since 2015.
Daily News Egypt Published in Daily News Egypt on 05 - 12 - 2019

Rameda Pharmaceutical private placement on the Egyptian Exchange (EGX) was oversubscribed 1.17 fold, the company said in a statement on Wednesday.
Egypt's second private-sector initial public offering (IPO) of the year, revitalising the country's lacklustre IPO market, is the largest Egyptian IPO and has been since 2015.
The company offered 49% stake of its share, 357.77m shares to institutional investors through an international offering, and 18.83m shares to retail investors in Egypt. Shares were priced at EGP 4.66 ($0.29) each.
Rameda will have a capital of EGP3.6bn ($222m) once the initial public offering is completed.
The group's senior management intends to use the net proceeds of the closed subscription to fund operational expansion, principally through molecule acquisitions but also through the opportunistic acquisition of pharmaceutical companies.
HSBC and Investec are joint global coordinators and bookrunners for the international offering, while CI Capital is joint bookrunner. Compass Capital is the IPO advisor, and Inktank is investor relations advisor.

Clic here to read the story from its source.